Cargando…

Sublingual Misoprostol versus Intramuscular Oxytocin for Prevention of Postpartum Hemorrhage in Uganda: A Double-Blind Randomized Non-Inferiority Trial

BACKGROUND: Postpartum hemorrhage (PPH) is a leading cause of maternal death in sub-Saharan Africa. Although the World Health Organization recommends use of oxytocin for prevention of PPH, misoprostol use is increasingly common owing to advantages in shelf life and potential for sublingual administr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Atukunda, Esther C., Siedner, Mark J., Obua, Celestino, Mugyenyi, Godfrey R., Twagirumukiza, Marc, Agaba, Amon G.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4219663/ https://www.ncbi.nlm.nih.gov/pubmed/25369200 http://dx.doi.org/10.1371/journal.pmed.1001752

Ejemplares similares

Provision of family planning vouchers and early initiation of postpartum contraceptive use among women living with HIV in southwestern Uganda: A randomized controlled trial
por: Atukunda, Esther C., et al.
Publicado: (2019)

Structured and sustained family planning support facilitates effective use of postpartum contraception amongst women living with HIV in South Western Uganda: A randomized controlled trial
por: Atukunda, Esther C, et al.
Publicado: (2021)

Measuring Post-Partum Haemorrhage in Low-Resource Settings: The Diagnostic Validity of Weighed Blood Loss versus Quantitative Changes in Hemoglobin
por: Atukunda, Esther Cathyln, et al.
Publicado: (2016)

Factors Associated with Pregnancy Intentions Amongst Postpartum Women Living with HIV in Rural Southwestern Uganda
por: Atukunda, Esther C., et al.
Publicado: (2018)

Potential Cost-Effectiveness of Prenatal Distribution of Misoprostol for Prevention of Postpartum Hemorrhage in Uganda
por: Lubinga, Solomon J., et al.
Publicado: (2015)

Correction: Potential Cost-Effectiveness of Prenatal Distribution of Misoprostol for Prevention of Postpartum Hemorrhage in Uganda
por: Lubinga, Solomon J., et al.
Publicado: (2016)

A Comparative Study of Sublingual Misoprostol Versus Intramuscular Oxytocin in the Active Management of Third Stage of Labor
por: Mishra, Shweta, et al.
Publicado: (2023)

Safety and Efficacy of Misoprostol versus Oxytocin for the Prevention of Postpartum Hemorrhage
por: Rajaei, Minoo, et al.
Publicado: (2014)

mHealth-Based Health Promotion Intervention to Improve Use of Maternity Care Services Among Women in Rural Southwestern Uganda: Iterative Development Study
por: Atukunda, Esther Cathyln, et al.
Publicado: (2021)

Women's Choice to Deliver at Home: Understanding the Psychosocial and Cultural Factors Influencing Birthing Choices for Unskilled Home Delivery among Women in Southwestern Uganda
por: Atukunda, Esther C., et al.
Publicado: (2020)

When Women Deliver at Home Without a Skilled Birth Attendant: A Qualitative Study on the Role of Health Care Systems in the Increasing Home Births Among Rural Women in Southwestern Uganda
por: Atukunda, Esther C, et al.
Publicado: (2020)

Evaluating the Feasibility, Acceptability, and Preliminary Efficacy of SupportMoms-Uganda, an mHealth-Based Patient-Centered Social Support Intervention to Improve the Use of Maternity Services Among Pregnant Women in Rural Southwestern Uganda: Randomized Controlled Trial
por: Atukunda, Esther C, et al.
Publicado: (2023)

High fever following postpartum administration of sublingual misoprostol
por: Durocher, J, et al.
Publicado: (2010)

Dose and side effects of sublingual misoprostol for treatment of postpartum hemorrhage: what difference do they make?
por: León, Wilfrido, et al.
Publicado: (2012)

The availability of six tracer medicines in private medicine outlets in Uganda
por: Birabwa, Catherine, et al.
Publicado: (2014)

Comparison of Clinical Efficacy and Safety between Misoprostol and Oxytocin in the Prevention of Postpartum Hemorrhage: A Meta-Analysis
por: Xu, Renmei, et al.
Publicado: (2022)

Randomized controlled trial comparing 400μg sublingual misoprostol versus placebo for prevention of primary postpartum hemorrhage
por: Zgaya, Rym, et al.
Publicado: (2020)

Optimal dose of misoprostol combined with oxytocin for preventing postpartum hemorrhage in cesarean section: A randomised controlled trial
por: Sringamwong, Wirawan, et al.
Publicado: (2022)

Retracted: Comparison of Clinical Efficacy and Safety between Misoprostol and Oxytocin in the Prevention of Postpartum Hemorrhage: A Meta-Analysis
por: Healthcare Engineering, Journal of
Publicado: (2023)

Efficacy of Rectal Misoprostol for Prevention of Postpartum Hemorrhage
por: Mirteimouri, Masoumeh, et al.
Publicado: (2013)

Access to oxytocin and misoprostol for management of postpartum haemorrhage in Kenya, Uganda and Zambia: a cross-sectional assessment of availability, prices and affordability
por: Kibira, Denis, et al.
Publicado: (2021)

Oxytocin Versus Misoprostol Plus Oxytocin in the Prevention of Postpartum Hemorrhage at a Semi-Urban Hospital in sub-Saharan Africa: A Retrospective Cohort Study
por: Numfor, Emmanuel, et al.
Publicado: (2020)

Sublingual misoprostol vs. oral misoprostol solution for induction of labor: A retrospective study
por: Amini, Mahdi, et al.
Publicado: (2022)

Intravaginal Isoniazid (INH) and Sublingual Misoprostol Versus Sublingual Misoprostol Alone for First-Trimester Induced Abortion: A Randomized Controlled Trial
por: Haghighi, Ladan, et al.
Publicado: (2023)

Use of misoprostol in the treatment of postpartum hemorrhage: a pharmacoepidemiological approach
por: Koch, Daeska Marcella, et al.
Publicado: (2019)

Outcome of misoprostol and oxytocin in induction of labour
por: Acharya, Trishna, et al.
Publicado: (2017)

Comparison of intramuscular methylergometrine, rectal misoprostol, and low-dose intravenous oxytocin in active management of the third stage of labor
por: Jain, Ruchi, et al.
Publicado: (2019)

Sublingual misoprostol and hyperpyrexia: case report with temperature curve
por: Tolefac, Paul Nkemtendong, et al.
Publicado: (2017)

Prophylactic effect of rectal and sublingual misoprostol on postpartum hemorrhage in mothers with preeclampsia following cesarean section surgery; a double-blind randomized controlled trial
por: Sadeghi Afkham, Mansoureh, et al.
Publicado: (2022)

Heat-stable sublingual oxytocin tablets as a potential needle-free approach for preventing postpartum hemorrhage in low-resource settings
por: Zhu, Changcheng, et al.
Publicado: (2018)

Cost-effectiveness and budget impact of heat-stable carbetocin compared to oxytocin and misoprostol for the prevention of postpartum hemorrhage (PPH) in women giving birth in India
por: Cook, John R., et al.
Publicado: (2023)

Modeling maternal mortality in Bangladesh: the role of misoprostol in postpartum hemorrhage prevention
por: Prata, Ndola, et al.
Publicado: (2014)

Quality of oxytocin and misoprostol in health facilities of Rwanda
por: Bizimana, Thomas, et al.
Publicado: (2021)

Comparison of Sublingual and Vaginal Misoprostol for Second-Trimester Pregnancy Terminations
por: Milani, Forozan, et al.
Publicado: (2014)

Effects of Motherwort Injection Versus Intramuscular Oxytocin for Preventing Postpartum Hemorrhage Among Women Who Underwent Cesarean Section
por: Li, Ming-xi, et al.
Publicado: (2022)

Sublingual Misoprostol versus Oxytocin to Induce Labor in Term Premature Rupture of Membranes in Pregnant Women: A Randomized Single-Blind Controlled Trial
por: Unthanan, Suchada, et al.
Publicado: (2022)

Misoprostol for Prevention of Postpartum Hemorrhage at Home Birth in Afghanistan: Program Expansion Experience
por: Haver, Jaime, et al.
Publicado: (2016)

Quality, availability and storage conditions of oxytocin and misoprostol in Malawi
por: Hagen, Nhomsai, et al.
Publicado: (2020)

Community perceptions about dementia in southwestern Uganda
por: Owokuhaisa, Judith, et al.
Publicado: (2020)

Oxytocin quality: evidence to support updated global recommendations on oxytocin for postpartum hemorrhage
por: Lambert, Peter, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_jr94e5chqhg20svac6kp7j9o9h